drugset / Trial / NCT02134002

A PET Exploration of the Mechanism of Action of Dopamine Beta-hydroxylase Inhibition in Cocaine Addicts

NCT02134002

RandomizedParallel-groupOpen-labelTreatment

Summary

This study represents a randomized, double blind placebo-controlled trial. Thirty cocaine dependant patients will be included in this study during their hospitalization for withdrawal. After the inclusion visit, they will be randomized to receive disulfiram 250 mg/day or placebo over the 15 days of their hospitalization. Main outcome criteria will be evaluated during two TEP imaging sessions with 11Craclopride, before and after stimulation by methylphenidate, 8 to 15 days after randomization.

Timeline

Start
2014-06
Primary completion
2016-04
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Disulfiram Small molecule 250 mg

Indications